Non-standardized vs. Standardized Screening for Dysphagia

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT05603897
Status
Recruiting
Apply to this trial

Conditions

  • Dysphagia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) — OTHER
    Upon 1-2 days of admission to inpatient rehabilitation, the MASA will be administered for approximately 20 minutes during initial speech language pathology evaluation. The MASA will be administered at bedside as a cognitive/speech language evaluation as well as oropharyngeal function examination.
  • Non-standardized clinical swallow evaluation — OTHER
    Participants will receive current standard of care for dysphagia screening and treatment.

Study Details

The purpose of this study is to compare two different screening tests for detecting dysphagia (difficulty swallowing) as well as the risk for aspiration (silent swallowing of liquids/solids into the lungs) in patients after an ischemic stroke (when a blood clot blocks or narrows an artery leading to the brain).

Key Dates

Start date
Apr 5, 2024
Status verified
Sep 2025
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: Mann Assessment of Swallowing Ability (MASA) Group
    Participants in this group will receive the MASA dysphagia screening once upon admission to inpatient rehabilitation for approximately 20 minutes.
  • Other: Non-standardized clinical swallow evaluation Group
    Participants in this group will receive standard of care treatment (dysphagia screening once upon admission to inpatient rehabilitation using a non-standardized clinical swallow evaluation for approximately 15 minutes).

Primary Outcome Measure

Dysphagia measured by MASA [ Time Frame: Up to 20 minutes ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Lynn Rehabilitation Center / University of MiamiMiamiFlorida33136
Gemayaret Alvarez, MD
[email protected]
305-243-6605
Claudia Santesteban-bidot, MS
[email protected]
305-585-9449
Gemayaret Alvarez, MD (PRINCIPAL_INVESTIGATOR)
Sarah Kurtevski, MD (SUB_INVESTIGATOR)

Find similar trials in Miami, FL

By research site
Lynn Rehabilitation Center / University of Miami· Miami, FL

Related Studies